Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy

Kidney International

Volumn 59, Issue 4, 2001, Pages 1567-1573

  Weir, Matthew R ^a   Ward, Mary Traver ^a   Blahut, Steven A ^a   Klassen, David K ^a   Cangro, Charles B ^a   Bartlett, Stephen T ^a   Fink, Jeffrey C ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Graft survival; Hypertension; Immunosuppression; Kidney graft; Progressive renal disease; Proteinuria; Transplantation

Indexed keywords

CALCINEURIN INHIBITOR; CREATININE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ADVERSE DRUG REACTION; ARTICLE; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035070048     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.0590041567.x     Document Type: Article

References (30)

1. The UNOS scientific transplant registry: Ten years of kidney transplants
2. Improved graft survival after renal transplantation in the United States, 1998 to 1996
3. Chronic renal allograft rejection: Immunologic and nonimmunologic risk factors
4. Chronic allograft nephropathy: An update
5. Risk factors for chronic rejection in renal allograft recipients
6. Immunosuppressant-induced nephropathy
7. Rethinking chronic allograft nephropathy: The concept of accelerated senescence
8. Metabolic factors have a major impact on kidney allograft survival
9. A novel approach to the treatment of chronic allograft nephropathy
10. Chronic allograft nephropathy: Effect of cyclosporine reduction and addition of mycophenolate mofetil on progression of renal disease
11. A SAS-IML program for implementing two-phase regression analysis of geophysical time series data
12. Half-life and risk factors for kidney transplant outcome-importance of death with function
13. Causes of renal allograft loss: Progress in the 1980s, challenges for the 1990s
14. The impact of an acute rejection episode on long-term renal allograft survival (t1/2)
15. The impact of acute rejection episodes on long-term graft function and outcome in 1347 primary renal transplants
16. Nephron supply is a major determinant of long-term renal allograft outcome in rats
17. Association of chronic kidney graft failure with recipient blood pressure
18. Increased renal tubular expression of transforming growth factor beta in human allografts correlates with cyclosporine toxicity
19. Nature and mediators of renal lesions in kidney transplant recipients given cyclosporine for more than one year
20. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK506 Kidney Transplant Study Group
21. The variable nature of chronic declines in renal allograft function
22. Both alloantigen-dependent and independent factors influence chronic allograft rejection
23. Chronic allograft dysfunction: Mechanisms and new approaches to therapy
24. Role of transforming growth factor-β1 in experimental chronic cyclosporine nephropathy
25. Intragraft TGF-β1 mRNA: A correlate of interstitial fibrosis and chronic allograft nephropathy
26. Intragraft expression of transforming growth factor β1 in isolated glomeruli from human renal transplants
27. Transforming growth factor βlevels in human allografts chronic fibrosis correlate with rate of decline in renal function
28. Transforming growth factor-beta in tissue fibrosis
29. Transforming growth factor-β and matrix protein expression on acute and renal chronic rejection of human renal allografts
30. Expression of apoptosis regulatory genes in chronic nephrotoxicity favors apoptosis